Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/160977| Title: | Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency. |
| Author: | Chaccour, Carlos Hammann, Felix Ramón García, Santiago Rabinovich, Regina |
| Keywords: | COVID-19 Salut pública Administració de medicaments COVID-19 Public health Administration of drugs |
| Issue Date: | 16-Apr-2020 |
| Publisher: | The American Society of Tropical Medicine and Hygiene |
| Abstract: | Ivermectin is a widely used drug for the treatment and control of several neglected tropical diseases.The drug has an excellent safety profile, with more than 2.5 billion doses distributed in the last 30 years, and its potential to reduce malaria transmission by killing mosquitoes is under evaluation in several trials around the world. Ivermectin inhibits the in vitro replication of some positive, single-stranded RNA viruses, namely, dengue virus (DNV), Zika virus, yellow fever virus, and others. |
| Note: | Reproducció del document publicat a: https://doi.org/10.4269/ajtmh.20-0271 |
| It is part of: | American Journal Of Tropical Medicine And Hygiene , 2020 |
| URI: | http://hdl.handle.net/2445/160977 |
| Related resource: | https://doi.org/10.4269/ajtmh.20-0271 |
| ISSN: | 0002-9637 |
| Appears in Collections: | Articles publicats en revistes (ISGlobal) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Chaccour_C_Am_J_Trop_Med_Hyg_2020.pdf | 65.18 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
